Supernus Pharmaceuticals (SUPN) Assets (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Assets of $1.4 billion for Q2 2026, up 3.31% year-over-year from $1.4 billion in Q2 2025, and down 4.84% on a QoQ basis from $1.5 billion in Q1 2026.
Supernus Pharmaceuticals (SUPN) Assets (2011 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Assets for 16 years, with the latest figure at $1.4 billion in Q2 2026.
- Assets for Q2 2026 came in at $1.4 billion, up 3.31% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.4 billion (up 3.31% YoY), and the FY2025 annual result was $1.5 billion, up 6.18% from the prior year.
- Assets eased to $1.4 billion in Q2 2026, from $1.5 billion in the prior quarter.
- Over five years, Assets peaked at $1.8 billion in Q1 2023 and troughed at $1.3 billion in Q4 2023.
- A 5-year average of $1.5 billion and a median of $1.4 billion in 2025 frame the typical range for Assets.
- The widest annual swing landed in 2024, when Assets retreated 27.22%; it then climbed 11.39% in 2026.
- A 5-year view of Assets shows it stood at $1.7 billion in 2022, then retreated by 24.95% to $1.3 billion in 2023, then rose by 7.08% to $1.4 billion in 2024, then grew by 6.18% to $1.5 billion in 2025, then slipped by 1.69% to $1.4 billion in 2026.
- Per Business Quant data, the three most recent Assets figures were $1.4 billion in Q2 2026, $1.5 billion in Q1 2026, and $1.5 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 6.18 Bn |
| 10 | Supernus Pharmaceuticals | 2.74 Bn | 2.37 Bn | 185.39 Mn | 1.43 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.43 Bn |
| Mar 31, 2026 | 1.50 Bn |
| Dec 31, 2025 | 1.45 Bn |
| Sep 30, 2025 | 1.42 Bn |
| Jun 30, 2025 | 1.38 Bn |
| Mar 31, 2025 | 1.35 Bn |
| Dec 31, 2024 | 1.37 Bn |
| Sep 30, 2024 | 1.34 Bn |
| Jun 30, 2024 | 1.32 Bn |
| Mar 31, 2024 | 1.30 Bn |
| Dec 31, 2023 | 1.28 Bn |
| Sep 30, 2023 | 1.29 Bn |
| Jun 30, 2023 | 1.29 Bn |
| Mar 31, 2023 | 1.79 Bn |
| Dec 31, 2022 | 1.70 Bn |
| Sep 30, 2022 | 1.69 Bn |
| Jun 30, 2022 | 1.69 Bn |
| Mar 31, 2022 | 1.64 Bn |
| Dec 31, 2021 | 1.69 Bn |
| Sep 30, 2021 | 1.56 Bn |